GlucoTrack (GCTK) Stock Chart & Stock Price History $5.75 -0.02 (-0.28%) As of 03:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GlucoTrack Stock Price Performance The GlucoTrack (GCTK) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.77%, with a year-to-date return of -98.71%. In the past month, the stock has decreased 1.30%, reflecting recent market activity. As of the latest close, GlucoTrack traded at $5.77 with a market cap of $2.77 million and volume of 18,732 shares. Receive GCTK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GlucoTrack and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.79%1 Month Performance-1.30%3 Month Performance-36.11%Year-To-Date Performance-98.71%1 Year Performance-99.77% GCTK Stock Chart for Monday, August, 18, 2025 GCTK Chart by TradingView GlucoTrack Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$5.72$5.77+0.87%$5.98$5.6818,732 shs$2.77 million08/14/2025$5.80$5.72-1.38%$5.95$5.6418,574 shs$2.73 million08/13/2025$5.76$5.80+0.69%$5.91$5.7117,183 shs$2.78 million08/12/2025$5.88$5.76-2.04%$6.00$5.7513,796 shs$2.77 million08/11/2025$5.82$5.88+1.03%$6.00$5.7121,887 shs$2.81 million08/08/2025$5.81$5.82+0.17%$5.99$5.728,865 shs$2.78 million08/07/2025$5.88$5.81-1.19%$6.00$5.7016,174 shs$2.79 million08/06/2025$5.83$5.88+0.86%$6.09$5.6421,549 shs$2.82 million08/05/2025$6.02$5.83-3.16%$6.15$5.7940,697 shs$2.80 million08/04/2025$6.23$6.02-3.37%$6.28$5.79189,968 shs$2.89 million Get the Latest News and Ratings for GCTK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GlucoTrack and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$6.15$6.23+1.30%$6.46$5.8167,025 shs$2.99 million07/31/2025$6.35$6.15-3.15%$6.49$6.1027,560 shs$2.95 million07/30/2025$6.57$6.35-3.35%$6.82$6.2726,907 shs$3.05 million07/29/2025$6.85$6.57-4.09%$6.98$6.4643,828 shs$3.27 million07/28/2025$7.42$6.85-7.68%$7.34$6.8571,611 shs$3.29 million07/25/2025$7.66$7.42-3.13%$7.91$7.1775,991 shs$3.56 million07/24/2025$8.29$7.66-7.60%$8.20$7.66121,400 shs$3.68 million07/23/2025$7.20$8.29+15.14%$8.85$6.92429,487 shs$3.95 million07/22/2025$7.97$7.20-9.66%$7.40$6.90345,481 shs$3.46 million07/21/2025$5.83$7.97+36.71%$9.75$7.7318.60 million shs$3.83 million07/18/2025$5.92$5.83-1.52%$6.28$5.512.04 million shs$2.80 million07/17/2025$5.34$5.92+10.86%$6.05$5.24320,849 shs$2.83 million Related Companies QTI Stock Price Chart LYRA Stock Price Chart TNON Stock Price Chart INBS Stock Price Chart LUCY Stock Price Chart ICU Stock Price Chart HSCS Stock Price Chart CODX Stock Price Chart SINT Stock Price Chart SSKN Stock Price Chart Receive GCTK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GlucoTrack and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GCTK) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlucoTrack, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlucoTrack With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access